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PERTUSSIS SENSITIZATION AS AN ANIMAL MODEL FOR THE
ABNORMAL BRONCHIAL SENSITIVITY OF ASTHMAt
For half a century anaphylaxis has served us as the animal model for
bronchial asthma, and it has served us very well, generating many substan-
tial contributions to the understanding of the pathogenesis of the disease
and to its treatment. We have just heard Patterson describe extensions of
this model which offer promise for still further developments, but as a
matter of fact anaphylaxis has been such a successful model that for years
we have been inclined to ignore facets of asthma that it does not explain.
The purpose of my presentation is to list some features of asthma which I
think a model should explain, to call your attention to a different animal
model which could help explain these features and to discuss briefly how
well the model and the disease correspond.
We are all painfully aware of the difficulties in the terminology of
chronic obstructive lung diseases, so for the purpose of the present discus-
sion I will use the following operational definition of asthma.' Bronchial
asthma is characterized by diffuse airway obstruction which is virtually
completely reversible, either spontaneously or with treatment. It is often
familial and is associated with eosinophilia in the blood or sputum. It is
further characterized by a remarkable bronchial sensitivity to various
kinds of stimulation, notably including cholinergic drugs and histamine.
Asthma has often been considered to be a syndrome like hypertension
produced by many agents, but we can also consider it a disease like diabetes
which has a common definable, though complicated, metabolic abnormality.
My argument starts with the premise that "asthma is asthma is asthma,"
and that the variety of etiologic features we recognize in our patients has
a single final common pathway of pathogenesis. The most important of
those features are allergic reactions, respiratory infections, air born irri-
tants, emotional disturbances and familial influences, and a major reason
for considering them provocative factors of a disease with a common under-
lying pathogenesis is that individual patients present all varieties of per-
mutations and combinations of them. A unifying hypothesis of asthma
should account for all of these factors and also explain the eosinophilia, the
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therapeutic benefit of small doses of corticosteroids, and the typical oc-
currence of attacks at night.
Attacks of asthma do, of course, sometimes follow exposure to pollen
or other allergens to which the patient has anaphylactic type of allergy. As
an end result of this allergic reaction a number of mediators such as hista-
mine, slow reacting substance, and kinins are released which cause broncho-
spasm and increased mucus production. The problem in considering that
asthma is fundamentally an allergic disease is that all patients with asthma
do not have demonstrable allergy, and all patients with allergy do not have
asthma. In fact, most people allergic to ragweed, for example, just have
hayfever, and bronchospasm is generally not part of the anaphylactic re-
action in non-asthmatic persons to insect stings or penicillin.2 The difference
between asthma and allergic rhinitis cannot be explained by known dif-
ferences in the antibody response or in the release of the mediators of
anaphylaxis. But there is a difference in the bronchial response to stimula-
tion. Bronchi of asthmatics respond excessively to acetylcholine and the
mediators of anaphylaxis.8` Bronchi of patients with hay fever are con-
siderably less sensitive than those of asthmatics although somewhat more
so than those of normal persons.78 People who have recovered from ana-
phylaxis to penicillin or insect stings respond normally.8 For these reasons
if there is a single basic abnormality in all patients with asthma it must be
related, not to allergy itself, but to this excessive bronchial response to
stimulation of any kind, including stimulation by mediators released by an
antigen antibody reaction or to homeostatic reflex vagal activity.
Several years ago Andor Szentivanyi suggested that pertussis sensitiza-
tion represents an experimental model for human asthma. Mice or rats
innoculated with Bordetella pertussis vaccine also have greatly increased
sensitivity to histamine, serotonin, acetylcholine, and anaphylaxis.'1'
Szentivanyi and others have studied the mechanisms of pertussis sensi-
tization in considerable detail and while all students of the phenomena do
not agree, most of the evidence points to the conclusion that pertussis
vaccine produces a blockade of beta adrenergic receptors."'' One of the
most striking features of this adrenergic blockade of pertussis-sensitized
animals is absence of elevation of blood sugar and free fatty acids after
epinephrine injection. Anaphylaxis, histamine, serotonin, or acetylcholine
all mobilize epinephrine, but in the pertussis-sensitized animal, unlike the
normal animal, this mobilization of epinephrine is not followed by the
expected rise in blood sugar and free fatty acids.
The pertussis model then, suggests that patients with asthma have as
their underlying disorder a partial beta adrenergic blockade. Normally the
tendency to bronchoconstriction from cholinergic or other stimulation is
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balanced by bronchodilitation from adrenergic activity. In asthma this
iormal homeostatic defence fails at the target cell level and airway ob-
struction develops as a consequence. In this hypothesis emotional dis-
turbances are viewed as causing trouble either by inhibiting adrenergic or
increasing cholinergic impulses. Cold air, dust, and fumes would provoke
bronchospasm through vagal reflexes which act unopposed by counter-
balancing beta adrenergic activity. Respiratory infections are known to
increase the sensitivity of the bronchial tree of both normal and asthmatic
subjects to cholinergic stimulation8 and in asthmatics killed influenza virus
vaccine also has this effect.15 The mechanism of influenza-vaccine increased
bronchial sensitivity is unknown, but it is possible that influenza vaccine
and other viruses increase the degree of beta adrenergic blockade.
The eosinophilia of asthma could be explained not only by the increased
production of eosinophiles as a consequence of the allergic reaction, but
also by a blockade of a normal beta adrenergic action of epinephrine in
lowering the number of these cells in circulation. Asthma is often con-
trolled by corticosteroids in small doses which are not effective in other
diseases like lupus erythematosus in which cells are injured by allergic
mechanisms. The mechanism of the therapeutic benefit of steroids in asthma
is unknown so the field is open to the speculator. It is known that corti-
costeroids are necessary for epinephrine to exert its action'e and that they
antagonize the effect of adrenergic blocking drugs" as well as partially
reversing the effects of pertussis vaccine in mice.`" Some of the thera-
peutic effects of corticosteroids in asthma could be explained as a restora-
tion of the normal response to adrenergic stimulation. Recumbent posture
increases airway resistance and also increases the bronchial response to
histamine.'7 These observations partially explain nocturnal attacks, but
asthma is often worse in the evening before the patient lies down. It has
been found that the sensitivity to histamine increases greatly at night.'8 An
additional explanation for nocturnal attacks might be that both catechola-
mine and corticosteroid blood levels are at a low ebb at this time of day,"''
thus reducing effective beta adrenergic stimulation at night.
A familial incidence of asthma is well established but it is not certain
whether the tendency to develop asthma is inherited or acquired in the
close setting of family life."' In any case according to the 8-adrenergic
blockade hypothesis the lesion that runs in families is either the blockade
itself or a genetic predisposition to develop the blockade.
It is evident, then, that /8 adrenergic blockade could explain much about
asthma and the hypothesis is at least superficially plausible. The next
question is how well does asthma correspond to the pertussis model? The
Table lists some relevant points of correspondence. I should say straight-
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TABLE 1. COMPARISON OF BRONCHIAL ASTHMA IN MAN AND
PERTUSSIS SENSMIZATION IN RATS AND MICE
Asthma Pertussis
Exaggerated response to:




SRS-A Yes No data
Acetylcholine Yes Yes
Response to epinephrine:
Reversal of the abnormal Diminished Diminished
state in status
Hyperglycemia Diminished? Diminished
Peripheral uptake of glucose Diminished? Diminished
Mobilization of FFA Diminished? Diminished
Vasodilitation Diminished Nodata
Tachycardia Not affected Diminished
Eosinopenia Diminished Diminished
Reduction of abnormality
by corticosteroids Yes Yes
Reproduction of pharmacological
sensitivity in normal subjects
by beta blocking drugs No? Yes
Eosinophilia Present Present
Lymphocytosis Absent Present
Antibody production Increased Increased
Reagins Often present Present transiently
away that few if any of the clinical studies have been conducted with the
rigor of the studies on pertussis sensitization in animals, and to date there
is no conclusive evidence of adrenergic blockade in asthma. At best studies
of subjects with intact autonomic nervous systems can only show autonomic
imbalance and cannot provide evidence of the site of the abnormality. In
the items followed by a question mark conflicting results have been re-
ported by different investigators.
I have already mentioned the similarity in sensitivity to anaphylaxis and
its mediators. The response of the pertussis-sensitized mouse6`' and of
asthmatic patients?- to epinephrine has been studied extensively. Epine-
phrine does not prevent fatal anaphylaxis in pertussis-sensitized animals,
but does in normal animals.1' While epinephrine is usually effective in
terminating an attack of asthma it is not effective in status asthmaticus.
Airway obstruction by mucus plugs, and diminished cellular response to
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epinephrine because of respiratory acidosis are probable explanations for
the lack of effect, but in a few patients epinephrine injection actually in-
creases the airway obstruction. In other words the usual bronchodilating
effect of epinephrine is reversed and bronchoconstriction occurs. A similar
reversal occurs in animals after beta adrenergic blockade." Blockade of
beta receptors allows the stimulation of alpha receptors to become evident,
and reversal of the expected epinephrine effect in severe asthma suggests
that beta blockade is present.
There is not time to discuss fully epinephrine-induced hyperglycemia,
but there are two major mechanisms involved. Epinephrine stimulates the
release of glucagon which in turn promotes hepatic glycogenolysis and
release of glucose into the circulation." Epinephrine also activates muscle
glycogenolysis directly and prevents glucose from entering the cell.' The
end result of both is an elevation of blood sugar. In mice sensitized with
pertussis or given beta blocking drugs, the hyperglycemic effect of both
glucagon and epinephrine is reduced, and the peripheral uptake and utiliza-
tion of glucose is increased.'1 The effects of beta blockade on blood sugar
levels in man are less definite, but in our species, too, they block the effect
of epinephrine on peripheral utilization of glucose and lactic acid pro-
duction.'
There have been several studies on the hyperglycemic effect of sympa-
thomimetic drugs in asthma and the results are conflicting.""' " None of
the studies is free of flaws in experimental design but some investigators
have concluded that asthmatics have a diminished hyperglycemic response
to glucose due mainly to increased peripheral uptake. The response to
glucagon was not abnormal.
Mobilization of free fatty acids by epinephrine is impaired in the per-
tussis-sensitized animal." The data on asthma are conflicting, one study
reporting normal' and two reporting impaired response."
Asthmatic patients show a diminished vasodilator response to beta
adrenergic stimulation, but the chronotropic cardiac response is normal"'
or even exaggerated."
Corticosteroid drugs are effective in treating asthma and in preventing
death from anaphylaxis, histamine, and serotonin in pertussis-sensitized
mice. But they do not reverse the abnormal bronchial sensitivity of asth-
matics to methacholine, although I have found they do potentiate the effect
of ephedrine on the methacholine response.
Increased sensitivity to anaphylaxis and the mediators can be produced
in mice and guinea pigs with beta blocking drugs," and propranolol in-
creases the airway resistance in asthma" as well as in normal man," and
also increases the bronchial response of hay fever subjects to ragweed
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aerosol.' But Zaid and Bealu reported propranolol does not increase the
response of normal subjects to histamine or methacholine and Sly and co-
workers40 found it did not increase the exercise-induced bronchospasm of
asthmatic patients. The question of whether beta blockade can or cannot
reproduce the asthmatic state cannot yet be considered settled, however.
The beta receptors for inotropic and chronotropic cardiac activity have
important differences from the receptors for trachobronchial dilatation.'
The pattern of apparent adrenergic blockade in asthma more closely re-
sembles the blockade produced by methoxamine derivatives than pro-
pranolol. The methoxamine derivatives block the metabolic and smooth
muscle beta receptors more effectively than the cardiac receptors."' Pro-
pranolol, on the other hand, more effectively blocks the cardiac receptors."
A similar dissociation of the cardiac and smooth muscle beta receptors can
be achieved with dichloroisoproterenol and alpha methyl-dichloroisopro-
terenol.' Butoxamine should be examined as a possible asthmogenic agent
before we accept the conclusion that pharmacologic beta blockade does
not reproduce asthma. It is quite possible that asthma is associated with a
greater degree of blockade in the bronchi than can be readily achieved in
man with customary doses of propranolol.
Eosinophilia is a prominent feature of both asthma and pertussis sensi-
tization, and in both the eosinophiles are resistant to the eosinopenic effect
of epinephrine.'
Lymphocytosis is as prominent in pertussis-innoculated animals' as it is
in whooping cough, but lymphocytosis is not present in asthma.
Pertussis vaccine is an excellent adjuvant for increasing antibody pro-
duction in all species studied, includingman.'7 In rats and mice this increased
antibody response includes a gamma1 antibody which has many of the
characteristics of the human reagin frequently associated with asthma.'-'
Patients with asthma also have a modest increase in antibody response to
bovine serum albumin' and dextran,5 but increased antibody response of
asthmatic subjects seems to be found only when the antigen is introduced
through mucus membranes.`"
The resemblance can be summed up by saying that in pertussis sensitiza-
tion there appears to be an intense and widespread beta blockade, but it is
transient, disappearing after about two weeks. The blockade in asthma, if
it exists, is partial and involves only some organs, notably the bronchi, but
lasts for years. The pertussis model, it seems to me, is valuable in provok-
ing a fresh approach to the old idea of autonomic imbalance in asthma. The
beta blockade hypothesis is testable, indirectly at least, and possibly directly.
Many intriguing questions come to mind. What could bring on the beta
blockade in the first place? Do respiratory infections in fact produce a
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blockade? Is the bronchospasm of chronic bronchitis related to asthma and
mediated by a similar mechanism? And most important of all, will this
model stimulate any new ideas for treatment of asthma?
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